Lupus Nephritis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Lupus Nephritis Clinical Trial Report Overview
A total of 434 lupus nephritis clinical trials were conducted as of February 2024. The lupus nephritis clinical trial report provides a comprehensive understanding of the lupus nephritis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· North America · Europe · Middle East and Africa · South and Central America |
Key Countries | · China
· United States · Japan · Spain · South Korea · Germany · Mexico · Russia · Italy · United Kingdom |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Novartis AG
· F. Hoffmann-La Roche Ltd · Aurinia Pharmaceuticals Inc · AstraZeneca Plc · Bristol-Myers Squibb Co |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Lupus Nephritis Clinical Trials Segmentation by Regions and Countries
As of February 2024, Asia-Pacific led the lupus nephritis clinical trials landscape with more than 40% of the clinical trials conducted there
The key regions considered for lupus nephritis clinical trials analysis are Asia-Pacific, North America, Europe, Middle East and Africa, and South and Central America.
In the country-wise analysis, China had the highest number of lupus nephritis clinical trials as of February 2024. Mexico had the highest average patient enrollment in lupus nephritis clinical trials during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Italy had the highest proportion of lupus nephritis to Respiratory clinical trials as of February 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico had the highest proportion of lupus nephritis to Respiratory clinical trials as of February 2024.
Lupus Nephritis Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Lupus Nephritis Clinical Trials
Lupus Nephritis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for lupus nephritis clinical trials are company, institution, and the government. As of February 2024, more than 48% of lupus nephritis clinical trials conducted were sponsored by company and institution sponsor type.
Lupus Nephritis Clinical Trials Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Lupus Nephritis Clinical Trials
Lupus Nephritis Clinical Trials - Competitive Landscape
As of February 2024, Novartis AG conducted the highest number of lupus nephritis clinical trials
A few of the leading sponsors for Lupus Nephritis clinical trials are:
- Novartis AG
- Hoffmann-La Roche Ltd
- Aurinia Pharmaceuticals Inc
- AstraZeneca Plc
- Bristol-Myers Squibb Co
Lupus Nephritis Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More about the Leading Sponsors of Lupus Nephritis Clinical Trials
Segments Covered in the Report
Lupus Nephritis Clinical Trials Regional Outlook (2024)
- Asia-Pacific
- North America
- Europe
- Middle East and Africa
- South and Central America
Lupus Nephritis Clinical Trials Country Outlook (2024)
- China
- United States
- Japan
- Spain
- South Korea
- Germany
- Mexico
- Russia
- Italy
- United Kingdom
Lupus Nephritis Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies with regard to investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
F. Hoffmann-La Roche Ltd
Aurinia Pharmaceuticals Inc
AstraZeneca Plc
Bristol-Myers Squibb Co
Otsuka Holdings Co Ltd
Astellas Pharma Inc
Johnson & Johnson
Biogen Inc
C. H. Boehringer Sohn AG & Co KG
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of lupus nephritis clinical trials in February 2024?
Asia-Pacific accounted for the highest number of lupus nephritis clinical trials as of February 2024.
-
Which country conducted the highest number of lupus nephritis clinical trials in February 2024?
China conducted the highest number of lupus nephritis clinical trials as of February 2024.
-
Which sponsor type was the most prominent in the lupus nephritis clinical trials in February 2024?
As of February 2024, most of the lupus nephritis clinical trials conducted were sponsored by company and institution sponsor type.
-
Which are the leading sponsors of lupus nephritis clinical trials?
A few of the leading sponsors of Lupus Nephritis clinical trials are Novartis AG, F. Hoffmann-La Roche Ltd, Aurinia Pharmaceuticals Inc, AstraZeneca Plc, Bristol-Myers Squibb Co among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.